Ardelyx, Inc.

Ardelyx, Inc.verified

ARDX

Price:

$6.75

Market Cap:

$1.58B

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or hear...[Read more]

Industry

Biotechnology

IPO Date

2014-06-19

Stock Exchange

NASDAQ

Ticker

ARDX

The ROE as of May 2024 (TTM) for Ardelyx, Inc. (ARDX) is -41.65%

According to Ardelyx, Inc.’s latest financial reports and current stock price. The company's current ROE is -41.65%. This represents a change of 268.00% compared to the average of -11.32% of the last 4 quarters.

Ardelyx, Inc. (ARDX) Historical ROE (quarterly & annually)

How has ARDX ROE performed in the past?

The mean historical ROE of Ardelyx, Inc. over the last ten years is -64.07%. The current -41.65% ROE has changed -35.00% with respect to the historical average. Over the past ten years (40 quarters), ARDX's ROE was at its highest in in the December 2022 quarter at 10.88%. The ROE was at its lowest in in the September 2021 quarter at -53.53%.

Quarterly (TTM)
Annual

Average

-64.07%

Median

-54.52%

Minimum

-191.44%

Maximum

-5.30%

Ardelyx, Inc. (ARDX) ROE by Quarter and Year

Discovering the peaks and valleys of Ardelyx, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 413.55%

Maximum Annual ROE = -5.30%

Minimum Annual Increase = -105.91%

Minimum Annual ROE = -191.44%

Quarterly (TTM)
Annual
YearROEChange
2023-39.60%-42.06%
2022-68.35%-64.30%
2021-191.44%155.99%
2020-74.79%47.03%
2019-50.86%-35.48%
2018-78.83%70.69%
2017-46.18%-20.63%
2016-58.19%113.92%
2015-27.20%413.55%
2014-5.30%-105.91%

Ardelyx, Inc. (ARDX) Average ROE

How has ARDX ROE performed in the past?

The current ROE of Ardelyx, Inc. (ARDX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-99.80%

5-year avg

-85.01%

10-year avg

-64.07%

Ardelyx, Inc. (ARDX) ROE vs. Peers

How is ARDX’s ROE compared to its peers?

Ardelyx, Inc.’s ROE is greater than BioLineRx Ltd. (-295.50%), less than Lexicon Pharmaceuticals, Inc. (25.60%), less than Seres Therapeutics, Inc. (340.60%), less than ImmunityBio, Inc. (103.04%), less than Zura Bio Limited (0%), greater than Hepion Pharmaceuticals, Inc. (-81.59%), greater than AVROBIO, Inc. (-268.74%), less than Verastem, Inc. (29.68%), greater than Mereo BioPharma Group plc (-119.96%), greater than Terns Pharmaceuticals, Inc. (-67.33%), greater than PDS Biotechnology Corporation (-35.55%), greater than Inozyme Pharma, Inc. (-145.99%), greater than HOOKIPA Pharma Inc. (-58.74%), greater than null (-47.31%),

Build a custom stock screener for Ardelyx, Inc. (ARDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ardelyx, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ardelyx, Inc. (ARDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ardelyx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Ardelyx, Inc.'s ROE?

How is the ROE calculated for Ardelyx, Inc. (ARDX)?

What is the highest ROE for Ardelyx, Inc. (ARDX)?

What is the 3-year average ROE for Ardelyx, Inc. (ARDX)?

What is the 5-year average ROE for Ardelyx, Inc. (ARDX)?

How does the current ROE for Ardelyx, Inc. (ARDX) compare to its historical average?